Bhutan vs New Zealand: Proportion of isolates with decreased susceptibility or resistance
Bhutan
1
in 2020
New Zealand
0.1
in 2020
Bhutan rank
8th
New Zealand rank
11th
Proportion of isolates with decreased susceptibility or resistance over time
- Bhutan
- New Zealand
How they compare
Bhutan currently reports 1 against 0.1 in New Zealand, a difference of 0.9.
That makes Bhutan's figure about 10.0 times New Zealand's.
The two have swapped places 3 times across 8 shared years of data; in 2009 it was New Zealand ahead.
Bhutan ranks 8th and New Zealand ranks 11th of 52 countries.
Bhutan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bhutan | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0 | 0 | — |
| 2010s | 2.03 | 0.3058 | 1.72 | Bhutan |
| 2020s | 1 | 0.1 | 0.9 | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Bhutan or New Zealand?
- Bhutan, at 1 against 0.1 in New Zealand as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Bhutan and New Zealand?
- 0.9, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and New Zealand?
- 8 years are reported by both, from 2009 to 2020.
- How do Bhutan and New Zealand rank globally for proportion of isolates with decreased susceptibility or resistance?
- Bhutan ranks 8th and New Zealand ranks 11th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.